STEVANATO GROUP SPA (STVN) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:STVN - IT0005452658 - Common Stock
20.95 USD
+0.11 (+0.53%)
Taking everything into account, STVN scores 5 out of 10 in our fundamental rating. STVN was compared to 57 industry peers in the Life Sciences Tools & Services industry. While STVN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. While showing a medium growth rate, STVN is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
STVN had positive earnings in the past year.
In the past year STVN had a positive cash flow from operations.
STVN had positive earnings in each of the past 5 years.
In the past 5 years STVN always reported a positive cash flow from operatings.
1.2 Ratios
With an excellent Return On Assets value of 5.71%, STVN belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
STVN has a better Return On Equity (9.60%) than 78.95% of its industry peers.
The Return On Invested Capital of STVN (7.91%) is better than 80.70% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STVN is below the industry average of 13.99%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| ROIC | 7.91% |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
1.3 Margins
With an excellent Profit Margin value of 11.72%, STVN belongs to the best of the industry, outperforming 80.70% of the companies in the same industry.
STVN's Profit Margin has improved in the last couple of years.
STVN's Operating Margin of 17.18% is amongst the best of the industry. STVN outperforms 80.70% of its industry peers.
In the last couple of years the Operating Margin of STVN has grown nicely.
The Gross Margin of STVN (28.83%) is worse than 73.68% of its industry peers.
In the last couple of years the Gross Margin of STVN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.18% | ||
| PM (TTM) | 11.72% | ||
| GM | 28.83% |
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
2. Health
2.1 Basic Checks
STVN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for STVN has been increased compared to 1 year ago.
Compared to 5 years ago, STVN has less shares outstanding
Compared to 1 year ago, STVN has an improved debt to assets ratio.
2.2 Solvency
STVN has an Altman-Z score of 5.16. This indicates that STVN is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.16, STVN belongs to the top of the industry, outperforming 82.46% of the companies in the same industry.
STVN has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
STVN has a Debt to Equity ratio (0.24) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.16 |
ROIC/WACC0.86
WACC9.15%
2.3 Liquidity
A Current Ratio of 1.79 indicates that STVN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.79, STVN is not doing good in the industry: 64.91% of the companies in the same industry are doing better.
A Quick Ratio of 1.22 indicates that STVN should not have too much problems paying its short term obligations.
The Quick ratio of STVN (1.22) is worse than 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.89% over the past year.
STVN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 27.29% yearly.
Looking at the last year, STVN shows a small growth in Revenue. The Revenue has grown by 6.98% in the last year.
STVN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.53% yearly.
EPS 1Y (TTM)14.89%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%16.67%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%9.12%
3.2 Future
STVN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.33% yearly.
Based on estimates for the next years, STVN will show a quite strong growth in Revenue. The Revenue will grow by 8.51% on average per year.
EPS Next Y11.64%
EPS Next 2Y16.04%
EPS Next 3Y19.33%
EPS Next 5Y18.33%
Revenue Next Year7.07%
Revenue Next 2Y7.92%
Revenue Next 3Y9%
Revenue Next 5Y8.51%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 32.73, STVN can be considered very expensive at the moment.
Based on the Price/Earnings ratio, STVN is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.59, STVN is valued a bit more expensive.
Based on the Price/Forward Earnings ratio of 27.50, the valuation of STVN can be described as expensive.
Based on the Price/Forward Earnings ratio, STVN is valued a bit cheaper than 70.18% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of STVN to the average of the S&P500 Index (24.03), we can say STVN is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.73 | ||
| Fwd PE | 27.5 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, STVN is valued a bit cheaper than the industry average as 75.44% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 20.62 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
STVN has a very decent profitability rating, which may justify a higher PE ratio.
STVN's earnings are expected to grow with 19.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.81
PEG (5Y)1.2
EPS Next 2Y16.04%
EPS Next 3Y19.33%
5. Dividend
5.1 Amount
STVN has a yearly dividend return of 0.30%, which is pretty low.
STVN's Dividend Yield is rather good when compared to the industry average which is at 0.09. STVN pays more dividend than 84.21% of the companies in the same industry.
With a Dividend Yield of 0.30, STVN pays less dividend than the S&P500 average, which is at 1.87.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.3% |
5.2 History
STVN has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
STVN pays out 10.77% of its income as dividend. This is a sustainable payout ratio.
DP10.77%
EPS Next 2Y16.04%
EPS Next 3Y19.33%
NYSE:STVN (12/24/2025, 8:02:26 PM)
20.95
+0.11 (+0.53%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners109.54%
Inst Owner Change1.69%
Ins Owners1.61%
Ins Owner ChangeN/A
Market Cap6.34B
Revenue(TTM)1.17B
Net Income(TTM)134.22M
Analysts83.53
Price Target29.57 (41.15%)
Short Float %4.51%
Short Ratio7.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.3% |
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP10.77%
Div Incr Years1
Div Non Decr Years1
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.49%
Min EPS beat(2)2.71%
Max EPS beat(2)10.28%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-7.68%
Max EPS beat(4)10.28%
EPS beat(8)3
Avg EPS beat(8)-5.73%
EPS beat(12)6
Avg EPS beat(12)-2.97%
EPS beat(16)10
Avg EPS beat(16)0.11%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.72%
Max Revenue beat(2)2.33%
Revenue beat(4)3
Avg Revenue beat(4)0.99%
Min Revenue beat(4)-0.71%
Max Revenue beat(4)2.33%
Revenue beat(8)3
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.02%
PT rev (1m)-0.38%
PT rev (3m)-0.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.35%
EPS NY rev (1m)0.1%
EPS NY rev (3m)0.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.07%
Revenue NY rev (1m)0.08%
Revenue NY rev (3m)0.08%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.73 | ||
| Fwd PE | 27.5 | ||
| P/S | 4.7 | ||
| P/FCF | N/A | ||
| P/OCF | 26.06 | ||
| P/B | 3.85 | ||
| P/tB | 4.1 | ||
| EV/EBITDA | 20.62 |
EPS(TTM)0.64
EY3.05%
EPS(NY)0.76
Fwd EY3.64%
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)0.8
OCFY3.84%
SpS4.46
BVpS5.44
TBVpS5.12
PEG (NY)2.81
PEG (5Y)1.2
Graham Number8.85
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.71% | ||
| ROE | 9.6% | ||
| ROCE | 10.52% | ||
| ROIC | 7.91% | ||
| ROICexc | 8.33% | ||
| ROICexgc | 8.74% | ||
| OM | 17.18% | ||
| PM (TTM) | 11.72% | ||
| GM | 28.83% | ||
| FCFM | N/A |
ROA(3y)6.9%
ROA(5y)7.65%
ROE(3y)11.86%
ROE(5y)15.36%
ROIC(3y)9.71%
ROIC(5y)10.46%
ROICexc(3y)11.09%
ROICexc(5y)13.59%
ROICexgc(3y)11.88%
ROICexgc(5y)15.21%
ROCE(3y)13.31%
ROCE(5y)14.16%
ROICexgc growth 3Y-28.59%
ROICexgc growth 5Y-6.94%
ROICexc growth 3Y-26.56%
ROICexc growth 5Y-4.42%
OM growth 3Y-5.27%
OM growth 5Y7.16%
PM growth 3Y-12.48%
PM growth 5Y7.86%
GM growth 3Y-3.05%
GM growth 5Y2.24%
F-Score5
Asset Turnover0.49
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.24 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 1.24 | ||
| Cap/Depr | 338.93% | ||
| Cap/Sales | 23.63% | ||
| Interest Coverage | 22.84 | ||
| Cash Conversion | 74.68% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.79 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | 5.16 |
F-Score5
WACC9.15%
ROIC/WACC0.86
Cap/Depr(3y)442.35%
Cap/Depr(5y)341.04%
Cap/Sales(3y)31.28%
Cap/Sales(5y)24.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.89%
EPS 3Y-6.42%
EPS 5Y27.29%
EPS Q2Q%16.67%
EPS Next Y11.64%
EPS Next 2Y16.04%
EPS Next 3Y19.33%
EPS Next 5Y18.33%
Revenue 1Y (TTM)6.98%
Revenue growth 3Y9.37%
Revenue growth 5Y15.53%
Sales Q2Q%9.12%
Revenue Next Year7.07%
Revenue Next 2Y7.92%
Revenue Next 3Y9%
Revenue Next 5Y8.51%
EBIT growth 1Y6.22%
EBIT growth 3Y3.61%
EBIT growth 5Y23.8%
EBIT Next Year69.85%
EBIT Next 3Y33.48%
EBIT Next 5Y24.61%
FCF growth 1Y70.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.91%
OCF growth 3Y5.33%
OCF growth 5Y29.6%
STEVANATO GROUP SPA / STVN FAQ
What is the ChartMill fundamental rating of STEVANATO GROUP SPA (STVN) stock?
ChartMill assigns a fundamental rating of 5 / 10 to STVN.
Can you provide the valuation status for STEVANATO GROUP SPA?
ChartMill assigns a valuation rating of 3 / 10 to STEVANATO GROUP SPA (STVN). This can be considered as Overvalued.
How profitable is STEVANATO GROUP SPA (STVN) stock?
STEVANATO GROUP SPA (STVN) has a profitability rating of 7 / 10.
What are the PE and PB ratios of STEVANATO GROUP SPA (STVN) stock?
The Price/Earnings (PE) ratio for STEVANATO GROUP SPA (STVN) is 32.73 and the Price/Book (PB) ratio is 3.85.
What is the earnings growth outlook for STEVANATO GROUP SPA?
The Earnings per Share (EPS) of STEVANATO GROUP SPA (STVN) is expected to grow by 11.64% in the next year.